Norovirus Treatment Market Report 2026

Norovirus Treatment Market Overview

• Norovirus Treatment market size has reached to $1.94 billion in 2025 • Expected to grow to $3.22 billion in 2030 at a compound annual growth rate (CAGR) of 10.6% • Growth Driver: Rise In Infectious Diseases Fueling The Growth Of The Market Due To Increasing Transmission In Overcrowded Urban Areas • Market Trend: Advancing Immunization Through mRNA Innovation To Combat Infectious Diseases • North America was the largest region in 2025.

What Is Covered Under Norovirus Treatment Market?

Norovirus treatment refers to supportive care aimed at relieving symptoms such as vomiting, diarrhea, and stomach pain caused by the virus. It primarily involves maintaining hydration, rest, and symptom management, as there is no specific antiviral medication for norovirus. The main treatments in norovirus treatment are electrolytes, intravenous fluids, antipyretics, analgesics, anti-diarrheal medications, and others. Electrolytes are minerals in the body that carry an electric charge and help regulate vital functions such as nerve signaling, muscle contractions, hydration, and pH balance. Diagnostic methods include stool tests, bacterial culture tests, and others. The various routes of administration include oral, intravenous, or subcutaneous and are used by various end users such as hospitals, clinics, and homecare environments.

What Is The Norovirus Treatment Market Growth Forecast?

The norovirus treatment market size is expected to see rapid growth in the next few years. It will grow to $3.22 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to growing demand for oral rehydration solutions, expansion of homecare services and telemedicine, increasing pediatric and elderly population focus, development of targeted supportive care therapies, rising healthcare expenditure and awareness campaigns. Major trends in the forecast period include increasing adoption of oral rehydration therapies, rising use of intravenous fluids in severe cases, growth in homecare and remote treatment options, expanded use of anti-diarrheal and symptom management drugs, focus on pediatric and geriatric norovirus care.

Global Norovirus Treatment Market Segmentation

1) By Treatment: Electrolytes, Intravenous Fluids, Antipyretics, Analgesics, Anti-Diarrheal, Other Treatments 2) By Diagnosis: Bacteria Culture Test, Stool Tests, Other Diagnosis 3) By Route Of Administration: Oral, Intravenous 4) By End User: Hospitals, Clinics, Homecare Settings Subsegments: 1) By Electrolytes: Oral Rehydration Salts (ORS), Sports Drinks, Pediatric Electrolyte Solutions 2) By Intravenous Fluids: Crystalloids, Colloids, Lactated Ringer's Solution 3) By Antipyretics: Acetaminophen (Paracetamol), Ibuprofen, Aspirin 4) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen-Based Analgesics 5) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Diphenoxylate-Atropine 6) By Other Treatments: Antiemetics, Probiotics, Zinc Supplements

What Is The Driver Of The Norovirus Treatment Market?

The increasing prevalence of infectious disease is expected to propel the growth of the norovirus treatment market going forward. Infectious diseases are illnesses caused by bacteria, viruses, fungi, or parasites that spread between people and include influenza, tuberculosis, HIV/AIDS, malaria, and norovirus. Infectious disease is increasing due to urban overcrowding, which facilitates faster transmission of pathogens among densely packed populations. Norovirus treatment helps reduce the impact of infectious disease by managing symptoms effectively and limiting the spread through proper hydration, hygiene, and isolation practices. For instance, in March 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, an estimated 10.8 million individuals, comprising 6.0 million men, 3.6 million women, and 1.3 million children, contracted tuberculosis globally in 2023. Therefore, the increasing prevalence of infectious disease is driving growth of the norovirus treatment industry.

Key Players In The Global Norovirus Treatment Market

Major companies operating in the norovirus treatment market are Abbott Laboratories, Reckitt Benckiser Group plc, Nestlé Health Science, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, Mylan (Viatris Inc.), Perrigo Company plc, Haleon plc, Church & Dwight Co. Inc., GlaxoSmithKline Consumer Healthcare, Sanofi Consumer Healthcare, Pfizer Consumer Healthcare, Ferring Pharmaceuticals, Fresenius Kabi AG, Baxter International Inc., B. Braun Melsungen AG, Hikma Pharmaceuticals PLC, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Pfizer Healthcare India Pvt. Ltd., Mead Johnson Nutrition (Reckitt), Danone Nutricia, Amneal Pharmaceuticals Inc., Ajanta Pharma Ltd.

Global Norovirus Treatment Market Trends and Insights

Major companies operating in the norovirus treatment market are focusing on developing innovative solutions, such as advanced mRNA vaccines, to accelerate the development of targeted immunization, enhance protection against severe infections, and reduce the global burden of norovirus-related illnesses. Advanced mRNA vaccines are next-generation immunizations that use specially engineered messenger RNA to instruct cells to produce specific proteins, triggering a targeted immune response with improved stability, efficacy, and adaptability against various infectious diseases. For instance, in October 2024, Moderna Inc., a US-based biotechnology company, partnered with the UK Health Security Agency (UKHSA), a UK-based government agency, and launched the world’s first Phase 3 trial of an mRNA norovirus vaccine (mRNA-1403) in the UK. This trial introduces a vaccine designed to target the highly contagious norovirus by instructing the body to produce viral proteins that stimulate a strong immune response without using the live virus. Unique features of the launch include its use of stabilized mRNA for improved durability, rapid development potential in response to evolving strains, and the ability to induce both antibody and T-cell responses.

What Are Latest Mergers And Acquisitions In The Norovirus Treatment Market?

In March 2024, Kenvue Inc., a US-based consumer healthcare company, partnered with the Association of Physicians of India (API) to promote public health awareness and preventive care initiatives. With this partnership, Kenvue aims to enhance clinical guidance on hydration and energy management for hospitalized patients with non-diarrheal illnesses by supporting evidence-based recommendations developed in collaboration with the Association of Physicians of India (API). The Association of Physicians of India (API) is an India-based professional body representing physicians practicing internal medicine.

Regional Insights

North America was the largest region in the norovirus treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Norovirus Treatment Market?

The norovirus treatment market includes revenues earned by entities by providing services such as symptom management, rehydration therapy, and stool tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The norovirus treatment market also includes sales of oral rehydration solutions (ORS), anti-nausea medications, thermometers, disinfectants, and cleaning products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Norovirus Treatment Market Report 2026?

The norovirus treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the norovirus treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.